OR WAIT 15 SECS
© 2025 MJH Life Sciences™ and Pharmaceutical Commerce - Biopharma Business News, Market Insights. All rights reserved.
Nicholas Saraceno is Editor of Pharmaceutical Commerce. He can be reached at nsaraceno@mjhlifesciences.com.
Krenar Komoni, founder and CEO of Tive, predicts that AI-driven automation and its accelerating impact on pharmaceutical supply chains will remain a headline topic at LogiPharma USA, as the industry faces growing pressure to innovate while balancing strict regulatory requirements.
In a recent panel discussion on supply chain security, Krenar Komoni emphasized the growing importance of collaboration among vendors, logistics providers, and technology companies to combat evolving threats in the industry. The conversation highlighted two main types of theft impacting the supply chain: direct theft, where goods are physically stolen from trailers or containers, and strategic theft, a more sophisticated form involving social engineering tactics where fake carriers impersonate legitimate ones to intercept shipments.
To address these risks, panelists discussed a multi-layered security approach. Tools like carrier vetting software, GPS trackers, seals, and even armed escorts were identified as part of a tiered defense system. Komoni stressed that no single solution can fully secure a supply chain; rather, companies must integrate multiple protective measures into their operations to build resilience.
A major highlight of the discussion was the shift in the pharmaceutical industry from passive monitoring to real-time tracking, accelerated by new technologies like the Solo Pro device. This transition enhances visibility and responsiveness in managing high-value or sensitive shipments.The panel also explored how closer partnerships between logistics providers, shippers, and tech firms are strengthening the supply chain. This “triangle” of collaboration allows for better implementation and use of advanced technologies, increasing trust and efficiency across the board.
Looking ahead, Komoni noted that AI and automation will play a larger role in supply chain security, helping to predict threats and streamline operations in a rapidly evolving environment. The session concluded with a clear takeaway: securing the supply chain requires continuous adaptation, strong relationships, and layered, technology-driven solutions.
A transcript of Komoni’s conversation with PC can be found below.
PC: What topics do you think will headline the 25th LogiPharma USA?
Komoni: I really believe the topic that we're going to continue to discuss is around how AI is infiltrated into our businesses, and how it's helping us run supply chains better, especially helping companies automate their supply chains today, I don't know if it feels only for me, but I believe the world's moving very fast, and the speed at which is accelerating, like the concept of singularity, everything is moving to an exponential pace at speed.
If you look at where open AI and ChatGPT were a year ago compared to 24 months ago, there's been tremendous amount of progress, and that progress is so much faster and better a month from now, but pharma moves a little slow because of regulatory requirements, which is a good thing, because these are medicines that are going in our bodies are in life saving, but it's going to have a put a lot of pressure on companies to innovate and innovate quicker than they have.
I believe five years from now, even three years from now, four years from now, this is a topic we're going to continue to discuss. And I believe it's a challenge on its own, but I'm very excited to be part of people who are going to help pharmaceutical companies tackle it.